Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) SHH

4.21

+0.01(+0.24%)

Updated at October 20 11:29AM

Currency In CNY

Valuation

Market Cap2.81B
Enterprise Value3B
P/E Ratio-14.35
PEG Ratio-1.18
Price/Sales Ratio1.67
Price/Book Ratio1.34
Enterprise/Revenue1.71
Enterprise/EBITDA-15.46

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.12
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.09

Income Statement

Revenue2.17B
Revenue/Share2.56
Gross Profit1.34B
EBITDA-113.44M
Net Income-317.22M
Diluted EPS-0.4

Balance Sheet

Total Cash695.15M
Total Cash/Share0.89
Total Debt781.47M
Total Debt/Equity0.32
Current Ratio1.8
Book Value Per Share3.3

Price History

52-Week Change19.83
52-Week High4.92
52-Week Low2.94
Moving Average 50 Days4.27
Moving Average 200 Days3.87

Statistics

Average Volume23.9M
Shares Outstanding789.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.13
Last Split Factor2:1
Last Split DateJuly 16, 2015